Literature DB >> 9316537

Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement.

J Reisinger1, S W Dubrey, M Lavalley, M Skinner, R H Falk.   

Abstract

OBJECTIVES: This study sought to determine the spectrum of electrophysiologic abnormalities found in patients with cardiac involvement due to AL (primary) amyloidosis and to evaluate the prognostic implications, particularly in relation to subsequent sudden death.
BACKGROUND: Only case reports, but no series of invasive electrophysiologic studies, exist in patients with cardiac AL.
METHODS: Twenty-five patients with biopsy-proven AL and cardiac involvement underwent standard invasive electrophysiologic studies.
RESULTS: The function of the sinus and the atrioventricular node was preserved in most patients, but the infra-His (HV) conduction times were usually abnormal. The mean (+/-SD) HV interval for the 25 patients was 79 +/- 18 ms (range 50 to 110), and 23 patients (92%) had an abnormally prolonged interval (> 55 ms). Marked HV prolongation (> or = 80 ms) occurred in 12 patients, 6 of whom had an interval > or = 100 ms. Among the 23 patients who died during follow-up, HV prolongation was the sole independent predictor of sudden death by multivariate analysis (p = 0.05).
CONCLUSIONS: Patients with cardiac AL are prone to disease in the His-Purkinje system. Prolongation of the HV interval is common and may not be suspected from the surface electrocardiogram in the presence of a narrow QRS complex. These patients have a high prevalence of sudden death, of which the HV interval is an independent predictor. The association of HV prolongation and sudden death is probably multifactorial, representing either a marker of severe myocardial infiltration with an increased propensity to lethal ventricular arrhythmias or electromechanical dissociation, or indicating severe conduction system disease eventually leading to complete atrioventricular block and bradycardic death.

Entities:  

Mesh:

Year:  1997        PMID: 9316537     DOI: 10.1016/s0735-1097(97)00267-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

2.  Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors:  Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

Review 3.  Sudden death in nondilated cardiomyopathies: pathophysiology and prevention.

Authors:  Anand Soni; Paul LeLorier
Journal:  Curr Heart Fail Rep       Date:  2005-09

4.  Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation.

Authors:  Abhishek Singla; William J Hogan; Stephen M Ansell; Francis K Buadi; David Dingli; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; David J Inwards; Patrick B Johnston; Martha Q Lacy; Mark R Litzow; Ivana N Micallef; Luis F Porrata; Shaji K Kumar
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-06       Impact factor: 5.742

Review 5.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

Review 6.  Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis.

Authors:  Ibtisam Ashraf; Mercedes Maria Peck; Ruchira Maram; Alaa Mohamed; Diego Ochoa Crespo; Gurleen Kaur; Bilal Haider Malik
Journal:  Cureus       Date:  2020-08-18

7.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

8.  Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.

Authors:  Alfonso Campanile; Fabiola B Sozzi; Ciro Canetta; Gian Battista Danzi
Journal:  Exp Clin Cardiol       Date:  2013

9.  Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function.

Authors:  Scott L Hummel; Stephen Skorcz; Todd M Koelling
Journal:  J Card Fail       Date:  2009-04-25       Impact factor: 5.712

10.  Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

Authors:  Michele Boldrini; Francesco Salinaro; Roberta Mussinelli; Ambra Raimondi; Alessio Alogna; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.